Transplantation for Cholangiocarcinoma

Howard Masuoka, Charles B. Rosen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cholangiocarcinoma (CCA) is a primary hepatic neoplasm that arises from malignant transformation of the biliary epithelium. Chronic biliary tree inflammation as occurs in primary sclerosing cholangitis (PSC) is a risk factor for the development of CCA. Surgical resection and liver transplantation following neoadjuvant therapy in patients with early extrahepatic CCA are the only potentially curative modalities. Biliary stenting, chemotherapy, radiation therapy, and photodynamic therapy are palliative treatment options for patients who are not surgical candidates. Liver transplantation following neoadjuvant therapy is an effective therapy for patients with hilar cholangiocarcinoma that is unresectable or arising in the setting of PSC.

Original languageEnglish
Pages (from-to)699-715
Number of pages17
JournalClinics in Liver Disease
Volume15
Issue number4
DOIs
StatePublished - Nov 2011

Fingerprint

Cholangiocarcinoma
Sclerosing Cholangitis
Neoadjuvant Therapy
Transplantation
Liver Transplantation
Klatskin Tumor
Photochemotherapy
Biliary Tract
Liver Neoplasms
Palliative Care
Radiotherapy
Epithelium
Inflammation
Drug Therapy
Therapeutics

Keywords

  • Acute cholangitis
  • Biliary stenting
  • Biliary stricture
  • Cholangiocarcinoma
  • Klatskin tumor
  • Liver transplantation
  • Living donor liver transplantation
  • Neoadjuvant therapy

ASJC Scopus subject areas

  • Hepatology

Cite this

Transplantation for Cholangiocarcinoma. / Masuoka, Howard; Rosen, Charles B.

In: Clinics in Liver Disease, Vol. 15, No. 4, 11.2011, p. 699-715.

Research output: Contribution to journalArticle

Masuoka, Howard ; Rosen, Charles B. / Transplantation for Cholangiocarcinoma. In: Clinics in Liver Disease. 2011 ; Vol. 15, No. 4. pp. 699-715.
@article{a5ec5cebc8ef479eb82351ac954e918f,
title = "Transplantation for Cholangiocarcinoma",
abstract = "Cholangiocarcinoma (CCA) is a primary hepatic neoplasm that arises from malignant transformation of the biliary epithelium. Chronic biliary tree inflammation as occurs in primary sclerosing cholangitis (PSC) is a risk factor for the development of CCA. Surgical resection and liver transplantation following neoadjuvant therapy in patients with early extrahepatic CCA are the only potentially curative modalities. Biliary stenting, chemotherapy, radiation therapy, and photodynamic therapy are palliative treatment options for patients who are not surgical candidates. Liver transplantation following neoadjuvant therapy is an effective therapy for patients with hilar cholangiocarcinoma that is unresectable or arising in the setting of PSC.",
keywords = "Acute cholangitis, Biliary stenting, Biliary stricture, Cholangiocarcinoma, Klatskin tumor, Liver transplantation, Living donor liver transplantation, Neoadjuvant therapy",
author = "Howard Masuoka and Rosen, {Charles B.}",
year = "2011",
month = "11",
doi = "10.1016/j.cld.2011.08.004",
language = "English",
volume = "15",
pages = "699--715",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Transplantation for Cholangiocarcinoma

AU - Masuoka, Howard

AU - Rosen, Charles B.

PY - 2011/11

Y1 - 2011/11

N2 - Cholangiocarcinoma (CCA) is a primary hepatic neoplasm that arises from malignant transformation of the biliary epithelium. Chronic biliary tree inflammation as occurs in primary sclerosing cholangitis (PSC) is a risk factor for the development of CCA. Surgical resection and liver transplantation following neoadjuvant therapy in patients with early extrahepatic CCA are the only potentially curative modalities. Biliary stenting, chemotherapy, radiation therapy, and photodynamic therapy are palliative treatment options for patients who are not surgical candidates. Liver transplantation following neoadjuvant therapy is an effective therapy for patients with hilar cholangiocarcinoma that is unresectable or arising in the setting of PSC.

AB - Cholangiocarcinoma (CCA) is a primary hepatic neoplasm that arises from malignant transformation of the biliary epithelium. Chronic biliary tree inflammation as occurs in primary sclerosing cholangitis (PSC) is a risk factor for the development of CCA. Surgical resection and liver transplantation following neoadjuvant therapy in patients with early extrahepatic CCA are the only potentially curative modalities. Biliary stenting, chemotherapy, radiation therapy, and photodynamic therapy are palliative treatment options for patients who are not surgical candidates. Liver transplantation following neoadjuvant therapy is an effective therapy for patients with hilar cholangiocarcinoma that is unresectable or arising in the setting of PSC.

KW - Acute cholangitis

KW - Biliary stenting

KW - Biliary stricture

KW - Cholangiocarcinoma

KW - Klatskin tumor

KW - Liver transplantation

KW - Living donor liver transplantation

KW - Neoadjuvant therapy

UR - http://www.scopus.com/inward/record.url?scp=80054957121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054957121&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2011.08.004

DO - 10.1016/j.cld.2011.08.004

M3 - Article

VL - 15

SP - 699

EP - 715

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 4

ER -